Shortcast: Early treatment of neonatal diabetes with oral glibenclamide in extreme prematurity
Release Date:
Professor Michel Polak reports success using a specialist preparation of oral glibenclamide in the management of neonatal diabetes in an extreme preterm infant subsequently found to have a KCNJ11 gene variant.
Early treatment of neonatal diabetes with oral glibenclamide in an extremely preterm infant
Alfonso Galderisi, et al
https://doi.org/10.1002/jmd2.12358
Shortcast: Early treatment of neonatal diabetes with oral glibenclamide in extreme prematurity